Add ANI As A Trusted Source For Reliable Information
Search For "eu drug regulator"
Updated : 4 years, 7 months ago IST
Brussels [Belgium], November 11 (ANI/Sputnik): The EU drug regulator advised on Thursday listing blood clots in the brain as a rare side effect of AstraZeneca's COVID-19 after observing cases that were not linked to a low platelet count.